GRIN2A and depressive symptom measurement: Therefore, regarding the role of GluN2A in the rapid antidepressant-like effect of ketamine, specific inhibition of GluN2A NMDAR may be developed to eliminate the side effects of ketamine and improve safe and effective innovative treatments for depression.